S A Rosenberg

20.2k total citations · 5 hit papers
134 papers, 15.8k citations indexed

About

S A Rosenberg is a scholar working on Immunology, Oncology and Molecular Biology. According to data from OpenAlex, S A Rosenberg has authored 134 papers receiving a total of 15.8k indexed citations (citations by other indexed papers that have themselves been cited), including 89 papers in Immunology, 67 papers in Oncology and 17 papers in Molecular Biology. Recurrent topics in S A Rosenberg's work include Immunotherapy and Immune Responses (69 papers), Immune Cell Function and Interaction (47 papers) and Cancer Immunotherapy and Biomarkers (30 papers). S A Rosenberg is often cited by papers focused on Immunotherapy and Immune Responses (69 papers), Immune Cell Function and Interaction (47 papers) and Cancer Immunotherapy and Biomarkers (30 papers). S A Rosenberg collaborates with scholars based in United States, Malaysia and Japan. S A Rosenberg's co-authors include James J. Mulé, Suzanne L. Topalian, Paul J. Spiess, Eli Glatstein, Nicholas P. Restifo, David Parkinson, J H Donohue, Richard I. Fisher, Mario Sznol and Arthur C. Louie and has published in prestigious journals such as The Journal of Experimental Medicine, Journal of Clinical Oncology and The Journal of Immunology.

In The Last Decade

S A Rosenberg

131 papers receiving 15.2k citations

Hit Papers

Randomized prospective study of the benefit of adjuvant r... 1985 2026 1998 2012 1998 1989 1995 1994 1985 250 500 750 1000
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Randomized prospective study of the benefit of adjuvant radiation therapy in the treatment of soft tissue sarcomas of the extremity.
    1998 1.1k citations William F. Sindelar, Suzanne L. Topalian et al. Journal of Clinical Oncology profile →
  2. Report of a committee convened to discuss the evaluation and staging of patients with Hodgkin's disease: Cotswolds meeting.
    1989 1.1k citations Eli Glatstein, S A Rosenberg et al. Journal of Clinical Oncology profile →
  3. Results of treatment of 255 patients with metastatic renal cell carcinoma who received high-dose recombinant interleukin-2 therapy.
    1995 1.0k citations G. Fyfe, Richard I. Fisher et al. Journal of Clinical Oncology profile →
  4. Identification of the immunodominant peptides of the MART-1 human melanoma antigen recognized by the majority of HLA-A2-restricted tumor infiltrating lymphocytes.
    1994 690 citations S A Rosenberg et al. The Journal of Experimental Medicine profile →
  5. Regression of established pulmonary metastases and subcutaneous tumor mediated by the systemic administration of high-dose recombinant interleukin 2.
    1985 593 citations S A Rosenberg, James J. Mulé et al. The Journal of Experimental Medicine profile →

Peers

S A Rosenberg
Claudia A. Seipp United States
Thomas Tursz France
Lothar Kanz Germany
Christian Peschel Germany
Maria Paola Martelli Italy
Taku Okazaki Japan
David Y. Mason United Kingdom
Franco Dammacco Italy
Paul H. Duray United States
Robert S. Negrin United States
Claudia A. Seipp United States
S A Rosenberg
Citations per year, relative to S A Rosenberg S A Rosenberg (= 1×) peers Claudia A. Seipp

Countries citing papers authored by S A Rosenberg

Since Specialization
Citations

This map shows the geographic impact of S A Rosenberg's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by S A Rosenberg with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites S A Rosenberg more than expected).

Fields of papers citing papers by S A Rosenberg

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by S A Rosenberg. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by S A Rosenberg. The network helps show where S A Rosenberg may publish in the future.

Co-authorship network of co-authors of S A Rosenberg

This figure shows the co-authorship network connecting the top 25 collaborators of S A Rosenberg. A scholar is included among the top collaborators of S A Rosenberg based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with S A Rosenberg. S A Rosenberg is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Gu, Wen‐Zhen, Ingrid B.J. Joseph, David J. Frost, et al.. (2003). The effect of A-409100, a potent and highly selective farnesyl transferase inhibitor in vitro and in vivo. 44. 1235. 2 indexed citations
2.
Kim, Christina J., Willem W. Overwijk, Matthew M. Roden, et al.. (1997). Dendritic Cells Infected with PoxvIn Vitro iruses Encoding MART-1/ Melan A Sensitize T Lymphocytes In Vitro. Journal of Immunotherapy. 20(4). 276–286. 77 indexed citations
3.
Kawakami, Yutaka & S A Rosenberg. (1996). T-cell recognition of self peptides as tumor rejection antigens. Immunologic Research. 15(3). 179–190. 45 indexed citations
4.
Bronte, Vincenzo, et al.. (1995). IL-2 enhances the function of recombinant poxvirus-based vaccines in the treatment of established pulmonary metastases.. The Journal of Immunology. 154(10). 5282–5292. 104 indexed citations
5.
Fyfe, G., Richard I. Fisher, S A Rosenberg, et al.. (1995). Results of treatment of 255 patients with metastatic renal cell carcinoma who received high-dose recombinant interleukin-2 therapy.. Journal of Clinical Oncology. 13(3). 688–696. 1041 indexed citations breakdown →
6.
Cohen, Philip, et al.. (1994). Murine epidermal Langerhans cells and splenic dendritic cells present tumor‐associated antigens to primed T cells. European Journal of Immunology. 24(2). 315–319. 93 indexed citations
7.
Sindelar, William F., Timothy J. Kinsella, Joel E. Tepper, et al.. (1993). Randomized trial of intraoperative radiotherapy in carcinoma of the stomach. The American Journal of Surgery. 165(1). 178–187. 58 indexed citations
8.
Topalian, Suzanne L. & S A Rosenberg. (1990). Tumor-infiltrating lymphocytes: evidence for specific immune reactions against growing cancers in mice and humans.. PubMed. 19–41. 26 indexed citations
9.
Weber, Jeffrey S. & S A Rosenberg. (1990). Effects of Murine Tumor Class I Major Histocompatibility Complex Expression on Antitumor Activity of Tumor-Infiltrating Lymphocytes. JNCI Journal of the National Cancer Institute. 82(9). 755–761. 28 indexed citations
10.
11.
Barba, David, et al.. (1989). Intratumoral LAK cell and interleukin-2 therapy of human gliomas. Journal of neurosurgery. 70(2). 175–182. 209 indexed citations
12.
Fisher, Beth, Beverly S. Packard, E.J. Read, et al.. (1989). Tumor localization of adoptively transferred indium-111 labeled tumor infiltrating lymphocytes in patients with metastatic melanoma.. Journal of Clinical Oncology. 7(2). 250–261. 261 indexed citations
13.
Lefor, Alan Kawarai, Avi Eisenthal, & S A Rosenberg. (1988). Heterogeneity of lymphokine-activated killer cells induced by IL-2. Separate lymphoid subpopulations lyse tumor, allogeneic blasts, and modified syngeneic blasts.. The Journal of Immunology. 140(11). 4062–4069. 31 indexed citations
14.
Kinsella, Timothy J., William F. Sindelar, Edward B. Lack, E Glatstein, & S A Rosenberg. (1988). Preliminary results of a randomized study of adjuvant radiation therapy in resectable adult retroperitoneal soft tissue sarcomas.. Journal of Clinical Oncology. 6(1). 18–25. 108 indexed citations
15.
Rosenberg, S A, S. Schwarz, & Paul J. Spiess. (1988). Combination Immunotherapy for Cancer:Synergistic Antitumor Interactions of Interleukin-2, Alfa Interferon, and Tumor-Infiltrating Lymphocytes. JNCI Journal of the National Cancer Institute. 80(17). 1393–1397. 106 indexed citations
16.
Weber, Jeffrey S., Gregory D. Jay, Karo Tanaka, & S A Rosenberg. (1987). Immunotherapy of a murine tumor with interleukin 2. Increased sensitivity after MHC class I gene transfection.. The Journal of Experimental Medicine. 166(6). 1716–1733. 83 indexed citations
17.
Ettinghausen, Stephen E., Maury Rosenstein, & S A Rosenberg. (1986). Evaluation in mice of the capillary leak syndrome (CLS) mediated by the systemic administration of recombinant interleukin-2 (IL-2). Fed. Proc., Fed. Am. Soc. Exp. Biol.; (United States). 1 indexed citations
18.
19.
Kaplan, M, et al.. (1983). Suppression of interleukin-2 production by methylprednisolone. Transplantation Proceedings. 15(1). 407–410. 10 indexed citations
20.
Hande, Kenneth R., et al.. (1977). Effect of hydration on plasma-methotrexate levels.. Munich Personal RePEc Archive (Ludwig Maximilian University of Munich). 61(7). 1393–6. 11 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Claudia A. Seipp Breakdown of academic impact, for papers by Thomas Tursz Breakdown of academic impact, for papers by Lothar Kanz Breakdown of academic impact, for papers by Christian Peschel Breakdown of academic impact, for papers by Maria Paola Martelli Breakdown of academic impact, for papers by Taku Okazaki Breakdown of academic impact, for papers by David Y. Mason Breakdown of academic impact, for papers by Franco Dammacco Breakdown of academic impact, for papers by Paul H. Duray Breakdown of academic impact, for papers by Robert S. Negrin
Rankless by CCL
2026